Evidence map›Paper›PMID 38051991›Full record

ReviewJournal of 3D printing in medicine2021

Industrial applications of 3D printing to scale-up production of COVID-19-related medical equipment.

Muhammad Zaheer Abbas

Abstract readReview
In one paragraph

Review in Journal of 3D printing in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Muhammad Zaheer AbbasFaculty of Business and Law, Queensland University of Technology, Brisbane, Australia.ORCID https://orcid.org/0000-0002-8301-885X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additive manufacturing or 3D printing allows the rapid conversion of information from digital 3D models into physical objects. The current COVID-19 crisis underscored the value of 3D-printing technology in addressing critical shortages in the medical product supply chain. This article provides a review of the significant role of additive manufacturing technologies in addressing the COVID-19 situation. This article concludes that 3D printing has an important role in global public health because of its potential to adapt to emerging situations far more easily and quickly as compared with conventional manufacturing methods. There is a need for further research to improve the technology to mass produce better quality products more economically. Currently, the 3D-printing industry is concentrated in the US and Western Europe. Policy efforts are needed to tap all markets across the globe in order to be better prepared for a future pandemic.

Indexed as

3D printingadditive manufacturingCOVID-19health emergencyindustrial applicationmedical equipment

Identifiers

PMID38051991
PMCPMC8357186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.